If approved by the medicines regulator Swissmedic, it would be the first protein-based vaccine to be made available in the country.
Because Novavax has no physical presence in Switzerland, it must apply for authorisation through the Swiss-based distributor Future Health.
Nuvaxovid has been approved for use in the EU by the European Medicines Agency (EMA). The Swiss application must be based on the same documents that were formerly submitted to the EMA.
The process “is intended to help ensure that medicines that are already authorised abroad can be made available to patients in Switzerland as quickly as possible”, said a Swiss government press releaseExternal link on Monday.
Nuvaxovid contains the coronavirus spike protein, which trains the body to identify the virus and swiftly produce antibodies. The vaccine can be stored in conventional fridges for up to six months.
Swissmedic has to date approved mRNA vaccines from Pfizer/BioNTech and Moderna plus the viral vector alternative from Johnson & Johnson for use in Switzerland.
More
More
Coronavirus: the situation in Switzerland
This content was published on
An overview of the latest Covid-related information in the Alpine nation.
Swiss price watchdog slams excessive prices for generic medicines
This content was published on
The cheapest generic medicines available in Switzerland are more than twice as expensive as in other countries, according to a study by the Swiss price watchdog.
Nature should not figure in net zero calculations: academic study
This content was published on
The natural removal of CO2 from the atmosphere by forests or oceans should not be included in the net-zero balance of climate protection measures, argue researchers.
This content was published on
None of the 15 major Swiss retail banks is meeting international climate and biodiversity targets, according to a ranking by WWF Switzerland.
This content was published on
Nestlé's new CEO Laurent Freixe, has presented plans for the future of the world's largest food company, after his first few weeks in office.
Swiss foreign minister calls on Moscow to end Ukraine war
This content was published on
It's high time Moscow ended its war against Ukraine, Swiss foreign minister Ignazio Cassis tells the UN Security Council.
This content was published on
The only alternative to the UN Palestinian agency’s work in Gaza is to allow Israel to run services there, Philippe Lazzarini, UNRWA Commissioner-General, told reporters in Geneva on Monday.
Study reveals food culture differences between Switzerland and neighbours
This content was published on
Three-quarters of Swiss people consider eating to be a pleasurable, social activity, a new survey reveals. Healthy eating, however, plays a much less important role, it found.
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.
Read more
More
Switzerland backs mRNA vaccine for booster jabs
This content was published on
Swiss teenagers, aged 12 to 15, and people who received initial doses of Janssen vector viral vaccine are advised to take a mRNA booster jab.
Covid vaccines: how to end the wait for billions of people
This content was published on
A waiver on intellectual property rights could be the key to getting more Covid drugs and vaccines to the developing world. But it's controversial.
Swiss regulator approves Pfizer/BioNTech booster for 16 and up
This content was published on
Swissmedic has approved the extension of Covid-19 boosters to all people 16 years of age and over for the Pfizer/BioNTech vaccine.
Vaccine alternative has limited impact on Covid campaign
This content was published on
The offer of a non-mRNA Covid vaccine in Switzerland has failed to speed up the government’s vaccination campaign, experts say.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.